|
Developing a universal Pneumococcal vaccine. SynAm Vaccine’s lead universal vaccine candidate addresses the critical unmet medical need in the marketplace by providing universal coverage against all 91 bacteria serotypes, while current marketed vaccines cover only a fraction of the serotypes. |
|